Selected research
Industry Growth & Trends
Global Monoclonal Antibody Medicine Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Monoclonal Antibody Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Monoclonal Antibody Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Monoclonal Antibody Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Monoclonal Antibody Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Monoclonal Antibody Medicine market include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer, Biogen and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Monoclonal Antibody Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Monoclonal Antibody Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Monoclonal Antibody Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Monoclonal Antibody Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Monoclonal Antibody Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Monoclonal Antibody Medicine Market by Company
Sanofi
Johnson & Johnson
Novartis
Merck
Roche
Eli Lilly
Pfizer
Biogen
Amgen
AbbVie
Sobi
Innovent Biologics
Celltrion
3SBIO
Monoclonal Antibody Medicine Segment by Type
Biologics
Biosimilars
Monoclonal Antibody Medicine Segment by Application
Cancer
Autoimmune Disease
Other
Monoclonal Antibody Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monoclonal Antibody Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monoclonal Antibody Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monoclonal Antibody Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Monoclonal Antibody Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Biologics
- Biosimilars
Applications
- Cancer
- Autoimmune Disease
- Other
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Merck
- Roche
- Eli Lilly
- Pfizer
- Biogen
- Amgen
- AbbVie
- Sobi
- Innovent Biologics
- Celltrion
- 3SBIO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Monoclonal Antibody Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Monoclonal Antibody Medicine Market Size by Region (2021-2032)
- 1.4.1 Global Monoclonal Antibody Medicine Market Size by Region (2021-2026)
- 1.4.2 Global Monoclonal Antibody Medicine Market Size by Region (2027-2032)
- 1.5 Key Regions Monoclonal Antibody Medicine Market Size (2021-2032)
- 1.5.1 North America Monoclonal Antibody Medicine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Monoclonal Antibody Medicine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Monoclonal Antibody Medicine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Monoclonal Antibody Medicine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Monoclonal Antibody Medicine Market Size Growth Rate (2021-2032)
2 Monoclonal Antibody Medicine Market by Type
- 2.1 Type Introduction
- 2.1.1 Biologics
- 2.1.2 Biosimilars
- 2.2 Global Monoclonal Antibody Medicine Market Size by Type
- 2.2.1 Global Monoclonal Antibody Medicine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Monoclonal Antibody Medicine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Monoclonal Antibody Medicine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Monoclonal Antibody Medicine Market Size by Regions
- 2.3.1 North America Monoclonal Antibody Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Monoclonal Antibody Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Monoclonal Antibody Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Monoclonal Antibody Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Monoclonal Antibody Medicine Market Size Breakdown by Type (2021-2026)
3 Monoclonal Antibody Medicine Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 Autoimmune Disease
- 3.1.3 Other
- 3.2 Global Monoclonal Antibody Medicine Market Size by Application
- 3.2.1 Global Monoclonal Antibody Medicine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Monoclonal Antibody Medicine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Monoclonal Antibody Medicine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Monoclonal Antibody Medicine Market Size by Regions
- 3.3.1 North America Monoclonal Antibody Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Monoclonal Antibody Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Monoclonal Antibody Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Monoclonal Antibody Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Monoclonal Antibody Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Monoclonal Antibody Medicine Industry Trends
- 4.2 Monoclonal Antibody Medicine Industry Drivers
- 4.3 Monoclonal Antibody Medicine Industry Opportunities and Challenges
- 4.4 Monoclonal Antibody Medicine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Monoclonal Antibody Medicine Revenue (2021-2026)
- 5.2 Global Monoclonal Antibody Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Monoclonal Antibody Medicine Key Company Headquarters & Area Served
- 5.4 Global Monoclonal Antibody Medicine Company, Product Type & Application
- 5.5 Global Monoclonal Antibody Medicine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Monoclonal Antibody Medicine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Monoclonal Antibody Medicine Players Market Share by Revenue in 2025
- 5.6.3 2025 Monoclonal Antibody Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Sanofi Monoclonal Antibody Medicine Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Monoclonal Antibody Medicine Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Novartis Monoclonal Antibody Medicine Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Merck Monoclonal Antibody Medicine Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Roche Monoclonal Antibody Medicine Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Eli Lilly Monoclonal Antibody Medicine Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Pfizer Monoclonal Antibody Medicine Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Biogen
- 6.8.1 Biogen Company Information
- 6.8.2 Biogen Business Overview
- 6.8.3 Biogen Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Biogen Monoclonal Antibody Medicine Product Portfolio
- 6.8.5 Biogen Recent Developments
- 6.9 Amgen
- 6.9.1 Amgen Company Information
- 6.9.2 Amgen Business Overview
- 6.9.3 Amgen Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Amgen Monoclonal Antibody Medicine Product Portfolio
- 6.9.5 Amgen Recent Developments
- 6.10 AbbVie
- 6.10.1 AbbVie Company Information
- 6.10.2 AbbVie Business Overview
- 6.10.3 AbbVie Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AbbVie Monoclonal Antibody Medicine Product Portfolio
- 6.10.5 AbbVie Recent Developments
- 6.11 Sobi
- 6.11.1 Sobi Company Information
- 6.11.2 Sobi Business Overview
- 6.11.3 Sobi Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sobi Monoclonal Antibody Medicine Product Portfolio
- 6.11.5 Sobi Recent Developments
- 6.12 Innovent Biologics
- 6.12.1 Innovent Biologics Company Information
- 6.12.2 Innovent Biologics Business Overview
- 6.12.3 Innovent Biologics Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Innovent Biologics Monoclonal Antibody Medicine Product Portfolio
- 6.12.5 Innovent Biologics Recent Developments
- 6.13 Celltrion
- 6.13.1 Celltrion Company Information
- 6.13.2 Celltrion Business Overview
- 6.13.3 Celltrion Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Celltrion Monoclonal Antibody Medicine Product Portfolio
- 6.13.5 Celltrion Recent Developments
- 6.14 3SBIO
- 6.14.1 3SBIO Company Information
- 6.14.2 3SBIO Business Overview
- 6.14.3 3SBIO Monoclonal Antibody Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 3SBIO Monoclonal Antibody Medicine Product Portfolio
- 6.14.5 3SBIO Recent Developments
7 North America
- 7.1 North America Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Monoclonal Antibody Medicine Market Size by Country (2021-2026)
- 7.3 North America Monoclonal Antibody Medicine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Monoclonal Antibody Medicine Market Size by Country (2021-2026)
- 8.3 Europe Monoclonal Antibody Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Monoclonal Antibody Medicine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Monoclonal Antibody Medicine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Monoclonal Antibody Medicine Market Size by Country (2021-2026)
- 10.3 South America Monoclonal Antibody Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Monoclonal Antibody Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Monoclonal Antibody Medicine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Monoclonal Antibody Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst